The toxins could potentially be used as ‘markers’ for doctors to identify Parkinson’s patients at a higher risk of developing dementia ...

Precision medicine holds enormous promise in enhancing treatment efficacy and advancing therapeutic development, leading to more equitable care. However, to realise this promise in all individuals ...

That said, however, a team of scientists at Kings College London believe they've uncovered one rather common indicator of Parkinson's, which they say can emerge during very early stages.

Cognitive decline and anxiety in Parkinson's disease are often only recognized at a late stage, yet they can greatly impact people's lives. Research by Marit Ruitenberg focuses on new tests and ...

The toxins could potentially be used as ‘markers’ for doctors to identify Parkinson’s patients at a higher risk of developing ...

Readers, many with Parkinson’s, respond to an article about Sue Goldie, who has the disease. Also: Tears over Trump’s America ...